279 related articles for article (PubMed ID: 23077850)
21. Pertussis in infants: preventing deaths and hospitalisations in the very young.
Wood N; Quinn HE; McIntyre P; Elliott E
J Paediatr Child Health; 2008 Apr; 44(4):161-5. PubMed ID: 18377367
[TBL] [Abstract][Full Text] [Related]
22. The impact of additional pertussis vaccine doses on disease incidence in children and infants.
Stein-Zamir C; Shoob H; Abramson N; Zentner G
Vaccine; 2010 Dec; 29(2):207-11. PubMed ID: 21055497
[TBL] [Abstract][Full Text] [Related]
23. Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI).
Muloiwa R; Wolter N; Mupere E; Tan T; Chitkara AJ; Forsyth KD; von König CW; Hussey G
Vaccine; 2018 Apr; 36(18):2385-2393. PubMed ID: 29602703
[TBL] [Abstract][Full Text] [Related]
24. Pertussis continues to put New Zealand's immunisation strategy to the test.
Grant CC; Reid S
N Z Med J; 2010 Apr; 123(1313):46-61. PubMed ID: 20581895
[TBL] [Abstract][Full Text] [Related]
25. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
[TBL] [Abstract][Full Text] [Related]
26. Potential strategies to reduce the burden of pertussis.
Forsyth K; Tan T; von König CH; Caro JJ; Plotkin S
Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S69-74. PubMed ID: 15876930
[TBL] [Abstract][Full Text] [Related]
27. [Pertussis in the Netherlands].
de Greeff SC; de Melker HE; Mooi FR
Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
[TBL] [Abstract][Full Text] [Related]
28. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010.
Guiso N; Liese J; Plotkin S
Hum Vaccin; 2011 Apr; 7(4):481-8. PubMed ID: 21389775
[TBL] [Abstract][Full Text] [Related]
29. Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.
Carlsson RM; Trollfors B
Vaccine; 2009 Sep; 27(42):5709-18. PubMed ID: 19679218
[TBL] [Abstract][Full Text] [Related]
30. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
31. The global pertussis initiative: Meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008.
Ulloa-Gutierrez R; Hozbor D; Avila-Aguero ML; Caro J; Wirsing von König CH; Tan T; Plotkin S
Hum Vaccin; 2010 Nov; 6(11):876-80. PubMed ID: 20980794
[TBL] [Abstract][Full Text] [Related]
32. Public health perspectives on the rising incidence of pertussis.
Judelsohn RG; Koslap-Petraco MB
Public Health Nurs; 2007; 24(5):421-8. PubMed ID: 17714226
[TBL] [Abstract][Full Text] [Related]
33. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
[TBL] [Abstract][Full Text] [Related]
34. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation.
Wiese-Posselt M; Hellenbrand W
Euro Surveill; 2010 Apr; 15(16):. PubMed ID: 20429999
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of pertussis in industrialized countries].
Baron S; Bégué P; Grimprel E
Sante; 1994; 4(3):195-200. PubMed ID: 7921686
[TBL] [Abstract][Full Text] [Related]
37. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
38. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
[TBL] [Abstract][Full Text] [Related]
39. Re-emergence of pertussis in Slovenia: time to change immunization policy.
Grgic-Vitek M; Klavs I; Kraigher A
Vaccine; 2008 Mar; 26(15):1874-8. PubMed ID: 18313178
[TBL] [Abstract][Full Text] [Related]
40. Accelerating control of pertussis in England and Wales.
Campbell H; Amirthalingam G; Andrews N; Fry NK; George RC; Harrison TG; Miller E
Emerg Infect Dis; 2012 Jan; 18(1):38-47. PubMed ID: 22260989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
